You must be logged to your Webikeo account.
drug-encapsulation-in-biocompatible-microparticle-for-drug-delivery

Drug encapsulation in biocompatible microparticles for drug delivery

Overview

In pharmaceutical area, Active Pharmaceutical Ingredient (API) encapsulation into biodegradable and biocompatible polymers is widely used for producing new smart Drug Delivery Systems.  The goal of these drug delivery systems is to supply doses of drugs for a sustained period of time at target specific sites in the body. This can be achieved by efficiently loading drugs into microparticles which will protect the API during physiological transport and release it when the microparticles have reached their specified target location(s).  To regulate the release of the drug, it is critical to controllably produce microparticles with known sizes and a homogeneous size distribution as the rate of drug release is proportional to microparticle size.

Among all techniques available for microparticle production, microfluidic and droplet based microfluidic ones appear as the best solutions to precisely control microparticle production in term of size, API loading and encapsulation efficiency.

In this webinar, we are going to discuss how microfluidics can allow API encapsulation into biocompatible and biodegradable microparticles for drug delivery.

 

What you’ll learn

  • How microfluidics can be used for API encapsulation in microparticle
  • What is droplet microfluidics.
  • Learn new method for microparticle production

 

Who should attend:

  • Researchers in chemistry/biology working on drug delivery, not familiar with microfluidics
  • Researchers in chemistry/biology working with microfluidics
  • Researchers in microfluidics

 

 


 

The webinar will be aired on Monday 30th april at :

  • 5PM Central European Summer Time

  • 11AM Eastern Time

  • 8AM  Pacific Time

Thursday, April 30th 2020

from 5:00PM to 6:00PM

(CEST)

93 subscribers | 60 mins

Subscription 100% free

Email notifications before the webinar

Chat zone to ask your questions

Replay until March 1, 2021